utd_medknow
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1053
Small font sizeDefault font sizeIncrease font size
Resource Links
   
 

 Article Access Statistics
    Viewed302    
    PDF Downloaded14    

Recommend this journal

 

 ORIGINAL ARTICLE

Significance of cancer testis-associated antigens (SPAG9 and FBXO39) in colon cancer


1 Department of Chemical Pathology, Medical Research Institute, Alexandria University, Egypt
2 Department of Human Genetics, Medical Research Institute, Alexandria University, Egypt
3 Department of Experimental and Clinical Surgery, Medical Research Institute, Alexandria University, Egypt
4 Department of Internal Medicine, Medical Research Institute, Alexandria University, Egypt
5 Alexandria University Students' Hospital, Egypt

Correspondence Address:
Ragaa A Ramadan,
Department of Chemical Pathology, Medical Research Institute, Alexandria University
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijc.IJC_873_19

PMID: 34380828

Background: Cancer testis antigens (CTA) are normally expressed in immune privileged tissues such as the testis. They are considered tumor-associated antigens because they are specifically expressed in different cancers. Their distinct nature rendered them appealing targets for cancer diagnosis, prognosis. and immunotherapy. We aimed to identify the association of two CTA genes with colon cancer (CC) in a cohort of Egyptian patients. Methods: We measured the relative gene expression levels of two CTAs: SPAG9 and FBXO39 in colonic tumor tissue and adjacent normal-appearing mucosa in 50 newly diagnosed colon cancer patients by real-time reverse transcription polymerase chain reaction. Gene expression was also studied in relation to demographic and pathological criteria. Results: SPAG9 and FBXO39 were overexpressed in 22% and 40% of cases, respectively. Overexpression of both genes was evident in 14% of cases. We report the significant expression of FBXO39 (P < 0.01) in tumor tissue compared to normal tissue. SPAG9 was significantly increased in large sized tumors compared to smaller sized tumors. Otherwise, there was no significant association between gene expression and the evaluated clinicopathological features (P > 0.05). Conclusions: SPAG9 and FBXO39 are possible CC diagnostic biomarkers. Further studies are warranted to validate our findings.




  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow